By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – WaferGen Biosystems today reported a significant rise in first-quarter revenues, as it recognized sales related to its SmartChip platform that is currently being evaluated by early-access customers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.